|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis显示文摘AIM: To analyze through meta-analyses the benefits of two types of stents in the inoperable malignant biliary obstruction.METHODS: A systematic review of randomized clinical trials(RCT) was conducted, with the last update on March 2015, using EMBASE, CINAHL(EBSCO), MEDLINE, LILACS/CENTRAL(BVS), SCOPUS, CAPES(Brazil), and gray literature. Information of the selected studies was extracted in sight of six outcomes: primarily regarding dysfunction, complication and reintervention rates; and secondarily costs, survival, and patency time. The data about characteristics of trial participants, inclusion and exclusion criteria and types of stents were also extracted. The bias was mainly assessed through the JADAD scale. This meta-analysis was registered in the PROSPERO database by the number CRD42014015078. The analysis of the absolute risk of the outcomes was performed using the software Rev Man, by computing risk differences(RD) of dichotomous variables and mean differences(MD) of continuous variables. Data on RD and MD for each primary outcome were calculated using the MantelHaenszel test and inconsistency was qualified and reported in χ2 and the Higgins method(I2). Sensitivity analysis was performed when heterogeneity was higher than 50%, a subsequent assay was done and other findings were compiled. Student's t-test was used for the comparison of weighted arithmetic means regarding secondary outcomes.RESULTS: Initial searching identified 3660 studies; 3539 were excluded through title, repetition, and/or abstract, while 121 studies were fully assessed and were excluded mainly because they did not compare self-expanding metal stents(SEMS) and plastic stents(PS), leading to thirteen RCT selected, with 13 articles and 1133 subjects meta-analyzed. The mean age was 69.5 years old, that were affected mostly by bile duct(proximal) and pancreatic tumors(distal). The preferred SEMS diameter used was the 10 mm(30 Fr) and the preferred PS diameter used was 10 Fr. In the metaanalysis, SEMS had lower overall stent dysfunction compared to PS(21.6% vs 46.8%, P < 0.00001) and fewer re-interventions(21.6% vs 56.6%, P < 0.00001), with no difference in complications(13.7% vs 15.9%, P = 0.16). In the secondary analysis, the mean survival rate was higher in the SEMS group(182 d vs 150 d, P < 0.0001), with a higher patency period(250 d vs 124 d, P < 0.0001) and a lower cost per patient(4193.98 vs 4728.65 Euros, P < 0.0985).CONCLUSION: SEMS are associated with lower stent dysfunction, lower re-intervention rates, better survival, and higher patency time. Complications and costs showed no difference. | Leonardo Zorrón Pu Eduardo Guimaraes Hourneaux de Moura Wanderley Marques Bernardo Felipe Iankelevich Baracat Ernesto Quaresma Mendonca AndréKondo Gustavo Oliveira Luz Carlos Kiyoshi Furuya Júnior Everson Luiz de Almeida Artifon | 2015 | World Journal of Gastroenterology2015，21，47： | 10 |
| 2 | Pancreatitis after endoscopic retrograde cholangiopancreatography:A narrative review显示文摘Acute post-endoscopic retrograde cholangiopancreatography pancreatitis(PEP)is a feared and potentially fatal complication that can be as high as up to 30%in high-risk patients.Pre-examination measures,during the examination and after the examination are the key to technical and clinical success with a decrease in adverse events.Several studies have debated on the subject,however,numerous topics remain controversial,such as the effectiveness of prophylactic medications and the amylase dosage time.This review was designed to provide an update on the current scientific evidence regarding PEP available in the literature. | Igor Braga Ribeiro Epifanio Silvino do Monte Junior Antonio Afonso Miranda Neto Igor Mendonça Proença Diogo Turiani Hourneaux de Moura Mauricio Kazuyoshi Minata Edson Ide Marcos Eduardo Lera dos Santos Gustavo de Oliveira Luz Sergio Eiji Matuguma Spencer Cheng Renato Baracat Eduardo Guimarães Hourneaux de Moura | 2021 | World Journal of Gastroenterology2021，27，20： | 5 |
| 3 | Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome显示文摘 | Teixeira Filho FL Baracat EC Lee TH | 2002 | J Clin Endocrinol Metab2002，87，3： | 1 |
| 4 | Estrogen therapy influence onpefiurethral vessels in postmenopausal ineontinence women using Dopplerveloeimetry analysis 显示文摘 | Kobata SA Girao MJ Baracat EC | 2011 | Maturitas2011，61，3： | 1 |
| 5 | Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis显示文摘 | Wojitani MD de Aguiar LM Baracat EC | 2012 | Arch Gynecol Obstet2012，285，1： | 1 |
| 6 | Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome显示文摘 | Baracat EC Benda JA | 2004 | J Clin Endocrinol Metab2004，89，11： | 1 |
| 7 | Stockpiling of transi- tional and classic primary follicles in ovaries of women with poly- cystic ovary syndrome 显示文摘 | Maciel GA Baracat EC Benda JA | 2004 | J Clin Endocrinol Metab2004，89，11： | 1 |
| 8 | High sensitivity moire interformetryasimplified approach显示文摘 | POST D BARACAT W E | 1981 | Exp Mech1981，21，3： | 1 |
| 9 | Fallopian tube origin of supposed ovarian high-grade serous carcinomas 显示文摘 | Diniz PM Carvalho JP Baracat EC | 2011 | Clinics (Sao Paulo)2011，66，1： | 1 |
| 10 | Androgen receptor gene polymorphism and polycystic ovary syndrome显示文摘 | Lin LH Baracat MC Maciel GA | 2013 | Int J Gynaecol Obstet2013，120，2： | 1 |
| 11 | Endometrial effects of bazedoxifene acetate,a novel selective estrogen receptor modulator,in postmenopausal women显示文摘 | RONKIN S NORTHINGTON R BARACAT E | 2005 | Obstet Gynecol2005，105，： | 1 |
| 12 | Benefits of soy isoflavone therapeutic regimen on menopausal symptoms显示文摘 | Han K K Soares J M Haidar M A Rodrigues de Lima G Baracat E C | 2002 | Obstet Gynecol2002，99，3： | 1 |
| 13 | Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women显示文摘 | Ronkin S Northington R Baracat E | 2005 | Obstet Gynecol2005，105，6： | 1 |
| 14 | Polycystic ovary syndrome:clinical and laboratory evaluation显示文摘 | Khoury M Y Baracat E C Pardini D P | 1998 | Sao Paulo Med J1998，114，： | 1 |
| 15 | Antileukotrienes in the treatment of asthma and allergic rhinitis显示文摘 | Ribeiro JD Toro AA Baracat EC | 2006 | J Pediatr(Rio J)2006，82，5： | 1 |
| 16 | Fallopian tube origin of supposed ovarian high-grade serous carcinomas 显示文摘 | Diniz PM Carvalho JP Baracat EC | 2011 | Clinics (Sao Paulo)2011，66，1： | 1 |
| 17 | Effect of oral contraceptive with and without associated estriol on ultrasound measurements of breast fibroadenoma: randomized clinical trial显示文摘 | Estevao RA Nazano AC Baracat EC | 2007 | Sao Panlo Med J2007，125，5： | 1 |
| 18 | Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome显示文摘 | Teixelra F F L Baracat E C Lee H | 2002 | J Clin Endocrinol Metab2002，87，3： | 1 |
| 19 | Aberrant expression of growth differentiation factor - 9 in cytes of women with polycystic ovary syndrome 显示文摘 | FILHO F L T BARACAT E C LEE T H | 2002 | J Clin Endocrinol Metab2002，87，3： | 1 |
| 20 | Histological compari- son of the alar nasal cartilages in unilateral cleft lip显示文摘 | Modolin M Baracat GZ Kamakura L | 2002 | Rev Hosp Clin Fac Med Sao Paulo2002，57，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员